Atai Life Sciences N.V.

biopharmaceutical company aiming to transform the treatment of mental health disorders

🤖

AI Overview

With $165K in lobbying spend across 7 quarterly filings, Atai Life Sciences N.V is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.

$165K
Total Spend
2
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$115K
2022$50K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Atai Life Sciences N.V. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy

DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services

DEA Restrictions on Psychedelics

Coverage and Reimbursement for Mental Health Services

Company Drug Development Updates

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.